Epigenetic silencing of glutaminase 2 in human liver and colon cancers
2013 · BMC Cancer · 56 citations
https://doi.org/10.1186/1471-2407-13-601
Y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
78
Papers
3.2K
Citations
20
h-index
30
i10-index
Ying Zhong is an academic researcher from The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine. The author has contributed to research in topics: Breast Cancer Treatment Studies & HER2/EGFR in Cancer Research & Breast Lesions and Carcinomas. The author has an h-index of 20, co-authored 67 publications.
Papers by this author
worksStriking life events associated with primary breast cancer susceptibility in women: a meta-analysis study
2013 · Journal of Experimental & Clinical Cancer Research · 53 citations
https://doi.org/10.1186/1756-9966-32-53
Expression of ALDH1 in breast invasive ductal carcinoma: an independent predictor of early tumor relapse
2013 · Cancer Cell International · 42 citations
https://doi.org/10.1186/1475-2867-13-60
Prognosis of subtypes of the mucinous breast carcinoma in Chinese women: a population-based study of 32-year experience (1983-2014)
2016 · Oncotarget · 26 citations
https://doi.org/10.18632/oncotarget.8778
HER2 amplification level is not a prognostic factor for HER2-positive breast cancer with trastuzumab-based adjuvant treatment: a systematic review and meta-analysis
2016 · Oncotarget · 20 citations
https://doi.org/10.18632/oncotarget.11541
Syndecan-1 as an immunogene in Triple-negative breast cancer: regulation tumor-infiltrating lymphocyte in the tumor microenviroment and EMT by TGFb1/Smad pathway
2023 · Cancer Cell International · 14 citations
https://doi.org/10.1186/s12935-023-02917-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat